Women aged 45 years or younger treated with percutaneous coronary intervention had a nearly 20 percent risk for major adverse cardiovascular events at three years, driven largely by high rates of target vessel revascularization, according to study data published in the American Journal of Cardiology. The retrospective analysis was conducted by researchers at the Capital Medical University in Beijing and UTMB and included 168 women aged 45 years or younger (mean age, 40.3 years) who underwent PCI.